Biopharma Competition Healthcare Provider 
PM360
AUGUST 24, 2023
As professionals with more than a half-century between us working in biopharma and diagnostics marketing and communications from the corporate (Ayaz Malik) and agency (Sandra Stahl) sides, we believe nurturing multigenerational teams is an especially powerful yet underutilized strategy for our industry.
PM360
AUGUST 9, 2022
Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. For biopharma, success in this space will require integrated models that are significantly different than what has been used with historic medicines. In oncology, it’s 47% less.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
MAY 21, 2024
“Streaming video provides life sciences advertisers with an efficient and effective way to reach patients at any stage of treatment and can help advance their patient marketing efforts.” Biopharma marketers are following their audiences and investment in this channel continues to increase.
Impetus Digital
MARCH 15, 2024
Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). However, with rapid growth comes growing pains.
Pharmaceutical Representative Training
JANUARY 29, 2025
These high prices are the result of multiple factors: theyre derived from living organisms making them sensitive and complex for both manufacturers and patients, research requires advanced technology to test for safety and effectiveness, and theyre in high demand without much competition.
PM360
JANUARY 24, 2025
In the pharmaceutical sector, this evolved further with privacycompliant data enrichment, enabling hyper-personalized messaging for healthcare providers (HCPs). By tracking preferences and behaviors, companies tailored interactions to make them more meaningful and effective.
Clarivate
DECEMBER 6, 2022
In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.
Expert insights. Personalized for you.
98 
Let's personalize your content